A Canadian-approved bioequivalent generic isn't a biosimilar approximation or an unregulated compound
When GLP-1 RAs are not used concomitantly with a sulphonylurea or insulin, routine glucose monitoring is unnecessary due to the low risk of developing hypoglycemia
As expected, higher doses were associated with greater weight loss
10.1038/bjc.2011.510 46 GuineyS
However, the challenge with current TRPV1 antagonists lies in their associated adverse effects, such as hyperthermia 24,25,26,27,28,29,30,31 and hypothermia 32,33,34 , caused by failures in thermoregulation